Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
Teodora Alexa‐Stratulat, Milica Pešić, Ana Čipak Gašparović, et al.
Drug Resistance Updates (2019) Vol. 46, pp. 100643-100643
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Tumour fatty acid metabolism in the context of therapy resistance and obesity
Andrew J. Hoy, Shilpa R. Nagarajan, Lisa M. Butler
Nature reviews. Cancer (2021) Vol. 21, Iss. 12, pp. 753-766
Closed Access | Times Cited: 259
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Luciana Mosca, Andrea Ilari, Francesco Fazi, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100742-100742
Closed Access | Times Cited: 228
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
Joanna Kopecka, Patrick Trouillas, Ana Čipak Gašparović, et al.
Drug Resistance Updates (2019) Vol. 49, pp. 100670-100670
Open Access | Times Cited: 217
CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma
Jingyue Yao, Jubo Wang, Ye Xu, et al.
Autophagy (2021) Vol. 18, Iss. 8, pp. 1879-1897
Open Access | Times Cited: 133
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
Muhlis Akman, Dimas Carolina Belisario, Iris C. Salaroglio, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 124
Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer
Ana Podolski-Renić, Ana Čipak Gašparović, Andreia Valente, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116363-116363
Closed Access | Times Cited: 23
Dual targeting of FR+CD44 overexpressing tumors by self-assembled nanoparticles quantitatively conjugating folic acid-hyaluronic acid to the GSH-sensitively modified podophyllotoxin
Chaozheng Zhang, Yao Chen, Yi Y. Zuo, et al.
Chemical Engineering Journal (2025), pp. 159276-159276
Closed Access | Times Cited: 3
The emergence of drug resistance to targeted cancer therapies: Clinical evidence
Ana Bela Sarmento‐Ribeiro, Andreas Scorilas, Ana Cristina Gonçalves, et al.
Drug Resistance Updates (2019) Vol. 47, pp. 100646-100646
Closed Access | Times Cited: 112
The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy
Shangui Liu, Abdur Rauf Khan, Xiaoye Yang, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 1-20
Closed Access | Times Cited: 96
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
Dimas Carolina Belisario, Joanna Kopecka, M. Pasino, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2598-2598
Open Access | Times Cited: 95
Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
Teodora Costea, Oana Vlad, Luminita Claudia Miclea, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 401-401
Open Access | Times Cited: 75
Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy
Zhe Zhang, Siyuan Qin, Yan Chen, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 2
Open Access | Times Cited: 69
DRESIS: the first comprehensive landscape of drug resistance information
Xiuna Sun, Yintao Zhang, Hanyang Li, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1263-D1275
Open Access | Times Cited: 58
Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer
Jia Wang, Wen‐Feng Zhang, Cun Liu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1884-1904
Open Access | Times Cited: 9
Role of Hypoxia-Associated Long Noncoding RNAs in Cancer Chemo-Therapy Resistance
Muhammad Affan Elahi, Aamira Tariq, Ambrin Malik, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 936-936
Open Access | Times Cited: 1
Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators
Bruno M. F. Gonçalves, David Cardoso, Maria‐José U. Ferreira
Molecules (2020) Vol. 25, Iss. 15, pp. 3364-3364
Open Access | Times Cited: 59
Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions
Alexander Tolios, Javier De Las Rivas, Eivind Hovig, et al.
Drug Resistance Updates (2019) Vol. 48, pp. 100662-100662
Closed Access | Times Cited: 58
Altered glycolysis results in drug‑resistant in clinical tumor therapy (Review)
Jinghui Peng, Yangyang Cui, Shipeng Xu, et al.
Oncology Letters (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 46
Mitochondrial temperature-responsive drug delivery reverses drug resistance in lung cancer
Lifo Ruan, Jun Chen, Chuanchao Du, et al.
Bioactive Materials (2021) Vol. 13, pp. 191-199
Open Access | Times Cited: 46
Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models
Aleksandra Filipiak-Duliban, Klaudia Brodaczewska, Arkadiusz Kajdasz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1166-1166
Open Access | Times Cited: 33
Emerging roles of endoplasmic reticulum stress in the cellular plasticity of cancer cells
Hao Wang, Kun Mi
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
Iris C. Salaroglio, Dimas Carolina Belisario, Muhlis Akman, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 24
The role of CircRNA/miRNA/mRNA axis in breast cancer drug resistance
Mohammad H. Ghazimoradi, Sadegh Babashah
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance
Shulong Cao, Jingyi Tang, Yi‐Chun Huang, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 30
Lysosome-Instructed Self-Assembly of Amino-Acid-Functionalized Perylene Diimide for Multidrug-Resistant Cancer Cells
Changjoon Keum, Ji-Young Hong, Doyeon Kim, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 13, pp. 14866-14874
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top